Venus Medtech Hangzhou Inc
HKEX:2500
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Venus Medtech Hangzhou Inc
Free Cash Flow
Venus Medtech Hangzhou Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Venus Medtech Hangzhou Inc
HKEX:2500
|
Free Cash Flow
-¥17.8m
|
CAGR 3-Years
73%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Free Cash Flow
¥682.2m
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Free Cash Flow
¥1.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
13%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Free Cash Flow
¥8.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Free Cash Flow
-¥11.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Free Cash Flow
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Venus Medtech Hangzhou Inc
Glance View
Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2019-12-10. The firm's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and TriGUARD3 Cerebral Embolic Protection Device.
See Also
What is Venus Medtech Hangzhou Inc's Free Cash Flow?
Free Cash Flow
-17.8m
CNY
Based on the financial report for Dec 31, 2025, Venus Medtech Hangzhou Inc's Free Cash Flow amounts to -17.8m CNY.
What is Venus Medtech Hangzhou Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
45%
Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for Venus Medtech Hangzhou Inc have been 73% over the past three years , 45% over the past five years .
